StockData
Rein Therapeutics, Inc. logo

Rein Therapeutics, Inc. (RNTX) KPIs and segments

RNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.36−0.04 (-10.90%)

Close on Nov 17, 2026Market cap $30.75MP/E –Yield 0.00%

KPIs & segments

Operating metrics and segments that drive Rein Therapeutics's business

Coming soon

This tab will track the numbers specific to Rein Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?